Gray area for new heart failure drug
Although the FDA approved BiDil for blacks with heart failure, it may work in anyone.
A "new" drug called BiDil (it's actually two old ones) is the first medication approved for a particular racial group, in this case blacks with moderate-to-severe heart failure. The interesting thing is, it may work just as well for members of other racial or ethnic groups with this all-too-common condition.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.